Overview A Study of OsrHSA in Adult Healthy Male and Female Volunteers Status: Completed Trial end date: 2020-07-13 Target enrollment: Participant gender: Summary A Phase 1 randomized, double blinded, placebo-controlled single dose escalation study of OsrHSA in adult healthy male and female volunteers Phase: Phase 1 Details Lead Sponsor: Healthgen Biotechnology Corp.